Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial
Dombernowsky, Sarah Louise, Damholt, Birgitte Bentz, Højby Rasmussen, Michael, Sværke, Claus, Kildemoes, Rasmus Juul
Published in Clinical pharmacokinetics (01.07.2024)
Published in Clinical pharmacokinetics (01.07.2024)
Get full text
Journal Article
Effect of Kidney or Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Somapacitan: Two Open-Label, Parallel-Group Trials
Bentz Damholt, Birgitte, Dombernowsky, Sarah Louise, Dahl Bendtsen, Mette, Bisgaard, Charlotte, Højby Rasmussen, Michael
Published in Clinical pharmacokinetics (01.08.2021)
Published in Clinical pharmacokinetics (01.08.2021)
Get full text
Journal Article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
Johannsson, Gudmundur, Gordon, Murray B, Højby Rasmussen, Michael, Håkonsson, Ida Holme, Karges, Wolfram, Sværke, Claus, Tahara, Shigeyuki, Takano, Koji, Biller, Beverly M K
Published in The journal of clinical endocrinology and metabolism (01.04.2020)
Published in The journal of clinical endocrinology and metabolism (01.04.2020)
Get full text
Journal Article
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3
Sävendahl, Lars, Battelino, Tadej, Højby Rasmussen, Michael, Brod, Meryl, Röhrich, Sebastian, Saenger, Paul, Horikawa, Reiko
Published in The journal of clinical endocrinology and metabolism (18.09.2023)
Published in The journal of clinical endocrinology and metabolism (18.09.2023)
Get full text
Journal Article
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
Papathanasiou, Theodoros, Agersø, Henrik, Damholt, Birgitte Bentz, Højby Rasmussen, Michael, Kildemoes, Rasmus Juul
Published in Clinical pharmacokinetics (01.09.2021)
Published in Clinical pharmacokinetics (01.09.2021)
Get full text
Journal Article
Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis
Doessing, Simon, Heinemeier, Katja M., Holm, Lars, Mackey, Abigail L., Schjerling, Peter, Rennie, Michael, Smith, Kenneth, Reitelseder, Søren, Kappelgaard, Anne‐Marie, Rasmussen, Michael Højby, Flyvbjerg, Allan, Kjaer, Michael
Published in The Journal of physiology (15.01.2010)
Published in The Journal of physiology (15.01.2010)
Get full text
Journal Article
Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics
de Schepper, Jean, Rasmussen, Michael Højby, Gucev, Zoran, Eliakim, Alon, Battelino, Tadej
Published in European journal of endocrinology (01.09.2011)
Published in European journal of endocrinology (01.09.2011)
Get full text
Journal Article
A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile
Rasmussen, Michael Højby, Olsen, Minna W. Brændholt, Alifrangis, Lene, Klim, Søren, Suntum, Mette
Published in The journal of clinical endocrinology and metabolism (01.10.2014)
Published in The journal of clinical endocrinology and metabolism (01.10.2014)
Get full text
Journal Article
Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency
Rasmussen, Michael Højby, Janukonyté, Jurgita, Klose, Marianne, Marina, Djordje, Tanvig, Mette, Nielsen, Lene F, Höybye, Charlotte, Andersen, Marianne, Feldt-Rasmussen, Ulla, Christiansen, Jens Sandahl
Published in The journal of clinical endocrinology and metabolism (01.03.2016)
Published in The journal of clinical endocrinology and metabolism (01.03.2016)
Get full text
Journal Article
Pegylated Long-Acting Human Growth Hormone Is Well-Tolerated in Healthy Subjects and Possesses a Potential Once-Weekly Pharmacokinetic and Pharmacodynamic Treatment Profile
Rasmussen, Michael Højby, Bysted, Britta V, Anderson, Thomas W, Klitgaard, Thomas, Madsen, Jesper
Published in The journal of clinical endocrinology and metabolism (01.07.2010)
Published in The journal of clinical endocrinology and metabolism (01.07.2010)
Get full text
Journal Article
Pegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone Deficiency
Søndergaard, Esben, Klose, Marianne, Hansen, Mette, Hansen, Birgit Sehested, Andersen, Marianne, Feldt-Rasmussen, Ulla, Laursen, Torben, Rasmussen, Michael Højby, Christiansen, Jens Sandahl
Published in The journal of clinical endocrinology and metabolism (01.03.2011)
Published in The journal of clinical endocrinology and metabolism (01.03.2011)
Get full text
Journal Article
Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial
Raschke, Michael, Rasmussen, Michael Højby, Govender, Shunmugam, Segal, David, Suntum, Mette, Christiansen, Jens Sandahl
Published in European journal of endocrinology (01.03.2007)
Published in European journal of endocrinology (01.03.2007)
Get full text
Journal Article
Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials
Juul, Rasmus Vestergaard, Rasmussen, Michael Højby, Agersø, Henrik, Overgaard, Rune Viig
Published in Clinical pharmacokinetics (01.01.2019)
Published in Clinical pharmacokinetics (01.01.2019)
Get full text
Journal Article
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects
Helleberg, Hans, Bjelke, Mads, Damholt, Birgitte Bentz, Pedersen, Palle Jacob, Rasmussen, Michael Højby
Published in European journal of pharmaceutical sciences (01.12.2021)
Published in European journal of pharmaceutical sciences (01.12.2021)
Get full text
Journal Article
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial
Miller, Bradley S, Blair, Joanne C, Rasmussen, Michael Højby, Maniatis, Aristides, Kildemoes, Rasmus Juul, Mori, Jun, Polak, Michel, Bang, Rikke Beck, Böttcher, Volker, Stagi, Stefano, Horikawa, Reiko
Published in The journal of clinical endocrinology and metabolism (01.12.2022)
Published in The journal of clinical endocrinology and metabolism (01.12.2022)
Get full text
Journal Article
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
Sävendahl, Lars, Battelino, Tadej, Højby Rasmussen, Michael, Brod, Meryl, Saenger, Paul, Horikawa, Reiko
Published in The journal of clinical endocrinology and metabolism (19.04.2022)
Published in The journal of clinical endocrinology and metabolism (19.04.2022)
Get full text
Journal Article
Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1–4, and IGFBPs-1–3 protease activity in obese subjects
Rasmussen, Michael Højby, Juul, Anders, Kjems, Lise Lund, Hilsted, Jannik
Published in European journal of endocrinology (01.10.2006)
Published in European journal of endocrinology (01.10.2006)
Get full text
Journal Article
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH
Miller, Bradley S, Blair, Joanne C, Rasmussen, Michael Højby, Maniatis, Aristides, Mori, Jun, Böttcher, Volker, Kim, Ho-Seong, Bang, Rikke Beck, Polak, Michel, Horikawa, Reiko
Published in The journal of clinical endocrinology and metabolism (17.11.2023)
Published in The journal of clinical endocrinology and metabolism (17.11.2023)
Get full text
Journal Article